VagiBiom® Feminine Support Suppositories Are Now Available in Publix Stores
BIOM Pharmaceutical Corporation (BIOM), a biotech company focused on natural microbiome-based consumer and medical products, today announced that it has launched two VagiBIOM® feminine care products in Publix, a leading supermarket and grocery chain in the Southeast United States with 1367 stores. Read more
VagiBiom® Feminine Support Suppositories Are Now Available in Publix Stores
BIOM Pharmaceutical Corporation (BIOM), a biotech company focused on natural microbiome-based consumer and medical products, today announced that it has launched two VagiBIOM® feminine care products in Publix, a leading supermarket and grocery chain in the Southeast United States with 1367 stores. Read more
Biom Pharmaceutical Published Clinical Safety & Efficacy of VagiBiom® Microbiome-based Probiotic Suppositories for Intimate Women’s Health
VagiBiom® microbiome-based probiotic suppositories have shown to be safe and efficacious in significantly improving symptoms and the vaginal health index in reproductive age and perimenopausal women with Bacterial Vaginosis. The double-blind, placebo-controlled clinical study was recently published in the internationally known publication “Scientific Reports.”. Read More
Biom Pharmaceutical Published Clinical Safety & Efficacy of VagiBiom® Microbiome-based Probiotic Suppositories for Intimate Women’s Health
VagiBiom® microbiome-based probiotic suppositories have shown to be safe and efficacious in significantly improving symptoms and the vaginal health index in reproductive age and perimenopausal women with Bacterial Vaginosis. The double-blind, placebo-controlled clinical study was recently published in the internationally known publication “Scientific Reports.”. Read More
VagiBIOM Lactobacillus suppository improves vaginal health index in perimenopausal women with bacterial vaginosis: a randomized control trial
Bacterial vaginosis (BV) can cause vaginal dysbiosis that may influence general vaginal health and pregnancy complications. Read More
VagiBIOM Lactobacillus suppository improves vaginal health index in perimenopausal women with bacterial vaginosis: a randomized control trial
Bacterial vaginosis (BV) can cause vaginal dysbiosis that may influence general vaginal health and pregnancy complications. Read More
Gardner Joins BIOM Pharmaceutical as Board Chairman
BIOM Pharmaceutical Corporation, an emerging biotech company focused on human microbiome technologies, is pleased to announce the appointment of Thomas E. Gardner as Chairman of the BIOM Board of Directors. Read More
Gardner Joins BIOM Pharmaceutical as Board Chairman
BIOM Pharmaceutical Corporation, an emerging biotech company focused on human microbiome technologies, is pleased to announce the appointment of Thomas E. Gardner as Chairman of the BIOM Board of Directors. Read More
Significant Broad-Spectrum Antiviral Activity of Bi121 against Different Variants of SARS-CoV-2
The SARS-CoV-2 pandemic has infected over 762 million people with over 6.9 million deaths, markedly affecting human life and existence. In the US alone, over 1.12 million deaths have been reported as of March 2023. Since its first report, several SARS-CoV-2 lineages evolved in the last 24 to 30 months.
Read More
Significant Broad-Spectrum Antiviral Activity of Bi121 against Different Variants of SARS-CoV-2
The SARS-CoV-2 pandemic has infected over 762 million people with over 6.9 million deaths, markedly affecting human life and existence. In the US alone, over 1.12 million deaths have been reported as of March 2023. Since its first report, several SARS-CoV-2 lineages evolved in the last 24 to 30 months. Read More
“Consumers are increasingly aware of the importance of cognitive and brain health in longevity,” says Bobban Subhadra, Ph.D., CEO & Founder, Biom Probiotics. “Traditionally, it was all about brain-boosting supplements. However, with the new research on gut microbiome—your gut good flora with its genetic elements and metabolites—it is obvious that gut flora plays a key role in optimizing cognitive brain health, which we call as microbiota-gut-brain-axis. Specifically, metabolites produced by gut flora, such as short-chain fatty acids play a key role in brain health and also prevent vascular dementia.”
“Consumers are increasingly aware of the importance of cognitive and brain health in longevity,” says Bobban Subhadra, Ph.D., CEO & Founder, Biom Probiotics. “Traditionally, it was all about brain-boosting supplements. However, with the new research on gut microbiome—your gut good flora with its genetic elements and metabolites—it is obvious that gut flora plays a key role in optimizing cognitive brain health, which we call as microbiota-gut-brain-axis. Specifically, metabolites produced by gut flora, such as short-chain fatty acids play a key role in brain health and also prevent vascular dementia.”
Biom Pharmaceuticals’ Antiviral Compound Bi121 Shows Broad-spectrum Activity Against Three Variants of SARS-CoV-2
Biom Pharmaceutical announced today that the preclinical studies of antiviral preparation Bi121 showed significant antiviral activity against various strains of SARS-CoV-2 and posted the preliminary results in the bioRxiv preprint collections. Read More
Biom Pharmaceuticals’ Antiviral Compound Bi121 Shows Broad-spectrum Activity Against Three Variants of SARS-CoV-2
Biom Pharmaceutical announced today that the preclinical studies of antiviral preparation Bi121 showed significant antiviral activity against various strains of SARS-CoV-2 and posted the preliminary results in the bioRxiv preprint collections. Read More
Microbiome Research Company Biom Pharmaceutical Launches Vee Mobile App To Maintain Optimal Feminine Health At Every Stage
Biom Pharmaceutical, a leading microbiome research company and creator of femtech brand VagiBiom® , has just launched Vee, a female-focused mobile health app that supports women’s health at each stage of the female journey. Read More
Microbiome Research Company Biom Pharmaceutical Launches Vee Mobile App To Maintain Optimal Feminine Health At Every Stage
Biom Pharmaceutical, a leading microbiome research company and creator of femtech brand VagiBiom® , has just launched Vee, a female-focused mobile health app that supports women’s health at each stage of the female journey. Read More
Biom Pharmaceutical Launches VagiBiom® Feminine Probiotics Product in All Walmart Stores
Biom Pharmaceuticals’ VagiBiom® feminine product is now available in all Walmart stores. This novel microbiome-focused formulation was presented at Walmart’s Made in USA Open Call competition in October 2020 and got selected for launch in all Walmart stores. Read More
Biom Pharmaceutical Launches VagiBiom® Feminine Probiotics Product in All Walmart Stores
Biom Pharmaceuticals’ VagiBiom® feminine product is now available in all Walmart stores. This novel microbiome-focused formulation was presented at Walmart’s Made in USA Open Call competition in October 2020 and got selected for launch in all Walmart stores. Read More
Health. Microbiome-Optimized healthy probiotic supplements and feminine hygiene products.
Biom Probiotics is a minority-owned small business founded by Dr. Bobban Subhadra and Vijitha Viv. The mission is to assure healthy life and longevity for all by balancing a healthy microbiome that functionally optimizes body functions such as immunity, cognition and longevity. Biom Probiotics has developed products for gut health to brain functions to feminine hygiene. The company has also secured five U.S. patents and trademarks on microbiome-based technologies. Read more
Health. Microbiome-Optimized healthy probiotic supplements and feminine hygiene products.
Biom Probiotics is a minority-owned small business founded by Dr. Bobban Subhadra and Vijitha Viv. The mission is to assure healthy life and longevity for all by balancing a healthy microbiome that functionally optimizes body functions such as immunity, cognition and longevity. Biom Probiotics has developed products for gut health to brain functions to feminine hygiene. The company has also secured five U.S. patents and trademarks on microbiome-based technologies. Read more
Sarasota, FL August 10, 2018
Biom Pharmaceutical Corporation today announced a keylandmarkin theirtechnology platform to develop drug and consumer care products that utilize modulating human microbiome. Human gut flora and its associated gene pool –human microbiome- is a powerful new organ that modulates all aspects of human physiology, health and longevity. Read more
Sarasota, FL August 10, 2018
Biom Pharmaceutical Corporation today announced a keylandmarkin theirtechnology platform to develop drug and consumer care products that utilize modulating human microbiome. Human gut flora and its associated gene pool –human microbiome- is a powerful new organ that modulates all aspects of human physiology, health and longevity. Read more